Life Technologies, Fluidigm Reach Licensing Deals, End Litigation

Under the cross- and sub-licensing deals, Fluidigm gains access to PCR-related patents from Life Tech, which in return receives access to imaging readers and other technologies from Fluidigm.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.